Latest results FY2026 · Prices updated Oct 30, 2026
HQ: Obu, AichiFounded 198244 employeesWebsite
A leading drugstore chain expanding nationwide from its base in the Chubu region. It specializes in stores with prescription pharmacies and pursues a total healthcare strategy.
Business segments (share of revenue)
Latest results
FY2026
vs. same period a year earlier
Company forecastFY2027
| Segment | Share | Revenue | Operating profit | Margin |
|---|---|---|---|---|
| Drugstore and Pharmacy Business | 100% | ¥1.0T | ¥48.6B | 4.8% |
Close (Oct 30, 2026)
¥1,304.5-20.6% (1Y)
Sugi HD -20.6% over 1Y, 25.8pt below the industry average (55 companies, +5.2%).
Reference chart of daily closing prices, not real-time quotes (split-adjusted; weekly closes before the last year). Updated Oct 30, 2026.
| Period | Revenue | Op. profit | Net income | Total assets | Revenue YoY |
|---|---|---|---|---|---|
| 2026FY | ¥1.0T | ¥48.6B | ¥45.0B | ¥614.5B | +15.1% |
| 2025FY | ¥878.0B | ¥42.6B | ¥25.7B | ¥495.1B | +17.9% |
| 2024FY | ¥744.5B | ¥36.6B | ¥22.0B | ¥390.6B | +11.5% |
| 2023FY | ¥667.6B | ¥31.7B | ¥19.0B | ¥351.9B | +6.7% |
| 2022FY | ¥625.5B | ¥32.1B | ¥19.4B | ¥334.8B | +3.8% |
| 2021FY | ¥602.9B | ¥34.0B | ¥21.1B | ¥345.9B | — |
Sources: annual securities reports, earnings releases and other public disclosures (May 2025)
Data may contain input errors. For reference only; we accept no responsibility for its accuracy.
